World of DTC Marketing

APRIL 7, 2021

QUICK READ: The compensation for pharma CEOs is starting to be reported and it’s off the charts. Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. Food and Drug Administration between 2010 and 2016 yet did taxpayers receive any discount?

Healthcare 162

Healthcare Healthcare Food and Drug Administration Pharma 162

PM360

MAY 15, 2023

After a developmental day of shadowing a pharma sales rep, the fire was lite and she joined the sales team never looking back, ultimately landing her a role at ConnectiveRx in 2010. Laura has educated the new ConnectiveRx employees on the “real” patient journey. Laura is not shy about sharing her cancer experience.

Sales 94

Sales Pharma sales reps Prescription Recruitment 94

PM360

FEBRUARY 1, 2024

The landscape is highly competitive with new prescription medications launching worldwide each year. Key stumbling blocks include payer activation and reimbursement hurdles, regulatory complexities, tepid market adoption by healthcare professionals (HCPs), field force inefficiencies, and obstacles in engaging and adopting patients.

Biopharma 59

Biopharma Competition Prescription Marketing 59

Clarivate

APRIL 18, 2024

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. RxPass offers more than 50 select prescriptions at no additional cost for $5 per month.

Retail 52

Retail Healthcare Healthcare Physicians 52

Pharmaceutical Technology

OCTOBER 25, 2022

More FDC products flowing into pharma pipelines. Between 2010 and the end of 2015, of the 655 New Drug Applications (NDAs) approved by the FDA, 63 were for FDCs. Among the numerous advantages FDCs offer patients, physicians, and pharmaceutical companies, several are particularly noteworthy. The numbers tell the story.

Manufacturing 52

Manufacturing Physicians Prescription FDA 52

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . At the same time, Cross says that this is not up to clinicians or the patients, but the payers. Product variation creates patient uncertainty. Interchangeability benefit variable.

Marketing 104

Marketing Physicians Competition Patients 104

Evolve Your Success

MAY 16, 2023

In his medical startup, he addresses the need for substance abuse mitigation in South Carolina using a unique approach where patients can come just like they’re going to a doctor’s clinic. There’s been such a crackdown on providers who provide opioids to patients so patients are turning to the streets.

Medical sales 52

Medical sales Sales Medical Doctors 52